Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ARHGAP32 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ARMC9 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CCIN - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DMPK - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ENTPD2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TMEM259 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CST9 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
RALGPS1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
IFT140 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RASGEF1C - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
IP6K2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HIST1H4A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FAM224A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC22A6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CAPS - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PODXL2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ADAMTS8 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CDR2L - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ATP5S - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on